Table 2.
Use of software reported in the systematic reviews
| Total (n = 152) | Cochrane (n = 75) | Non-Cochrane (n = 77) | |
|---|---|---|---|
| Software used for study selection | |||
| Covidence | 18 (12%) | 16 (21%) | 2 (3%) |
| DistillerSR | 2 (1%) | 0 (0%) | 2 (3%) |
| EndNote | 11 (7%) | 5 (7%) | 7 (9%) |
| Microsoft Excel | 2 (1%) | 1 (1%) | 1 (1%) |
| Rayyan | 2 (1%) | 0 (0%) | 2 (3%) |
| Other | 3 (2%) | 1 (1%) | 2 (3%) |
| None reported | 122 (80%) | 58 (77%) | 64 (83%) |
| Software used for data extraction | |||
| Covidence | 9 (6%) | 8 (11%) | 1 (1%) |
| DistillerSR | 2 (1%) | 0 (0%) | 2 (3%) |
| Microsoft Excel | 3 (2%) | 2 (3%) | 1 (1%) |
| Other | 4 (3%) | 1 (1%) | 3 (4%) |
| None reported | 133 (88%) | 63 (84%) | 70 (91%) |
| Software used for statistical analysis | |||
| Comprehensive Meta-Analysis | 6 (4%) | 0 (0%) | 6 (8%) |
| R | 10 (7%) | 0 (0%) | 10 (13%) |
| RevMan | 100 (66%) | 73 (97%) | 27 (35%) |
| Stata | 18 (12%) | 2 (3%) | 16 (21%) |
| Trial Sequential Analysis (TSA) | 4 (3%) | 2 (3%) | 2 (3%) |
| Other | 7 (5%) | 2 (3%) | 5 (6%) |
| None reported | 20 (13%) | 2 (3%) | 18 (23%) |
| Software used for grading of evidence | |||
| GRADEpro GDT | 72 (47%) | 70 (93%) | 2 (3%) |
| No software use reported | 12 (8%) | 0 (0%) | 12 (16%) |
Data given as number (percent); percentages rounded to the whole number; more than one software for the same purpose was used in some reviews